Diabetes

African Americans tend to have poorer health than whites. New research suggests a more welcoming atmosphere in school could make a difference early in life.

New research links the disposition to lower blood glucose levels.

The reality of a life with diabetes is much more than a matter of malfunctioning bodily organs.

The scientific evidence for whether eating too much sugar causes Type 2 diabetes and other diseases.

Key parallels and important distinctions.

University of California–San Francisco researcher Cristin Kearns dropped a promising career at the Kaiser Foundation to dig through sugar industry archives for a smoking gun. With help from the man who brought down Big Tobacco, she’s now proving that Big Sugar steered scientists away from looking at the ingredient’s harmful effects.

An early look at a Pacific Standard story that's currently only available to subscribers.

A morning buzz does the body good.

The morality of human embryonic stem cell research has long been contentious, but new discoveries could end the controversy.

Type 1 diabetes management is hard work, and any misstep could spell disaster. New advances in Big Data could ease the burden.

Inside the promising marriage between data and health care: How health quantification could alleviate Parkinson's symptoms and improve the lives of Type 1 diabetics.

It's becoming easier to track health data for our own casual use. But for some people—like Ph.D student Maria Qadri, a Type 1 diabetic—it could have a huge impact on quality of life.

New data shows that the incidence of Type 1 and Type 2 diabetes is growing among young Americans. But the rise of Type 1 remains mostly a mystery.

In an experiment, scientists found a correlation between low blood glucose and higher levels of spousal frustration.

Scientists are learning more about how we process feelings of gentle touch. New discoveries published Sunday could help restore fading sensations—and ease painful hypersensitivity.

A newspaper in the emirates suggests breaking bad dietary habits along with the fast.

Tiny numbers, big impacts.

The single participant in a groundbreaking—and controversial—study is forcing clinicians to confront the thorny ethical issues surrounding the sequencing of individual genomes to offer a glimpse at what the future of medicine may look like.

Dr. Jay Shubrook is flipping conventional insulin treatment upside-down—with startling results.